048410.KQ KOE
Hyundai Bioscience Co., Ltd.
1W: +2.9%
1M: +10.3%
3M: -15.4%
YTD: -39.0%
1Y: +21.6%
3Y: -41.2%
5Y: -62.5%
₩7,050.00 ($5.25)
+0.00 (+0.00%)
Weekly Expected Move ±9.4%
₩5720
₩6385
₩7050
₩7715
₩8380
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Balance Sheet Trends
Total Assets
$130.7B
+93.1% ▲
5Y CAGR: +6.9%
Total Liabilities
$20.0B
-29.1% ▼
5Y CAGR: -13.5%
Shareholders Equity
$110.7B
+180.7% ▲
5Y CAGR: +16.2%
Cash & Investments
$40.1B
+996.0% ▲
5Y CAGR: +15.8%
Total Debt
$17.8B
-33.0% ▼
5Y CAGR: -13.7%
Net Debt
-$4.5B
-119.7% ▼
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $9.2B | $2.7B | $1.8B | $3.7B | $22.3B |
| Short-Term Investments | $13.0B | $16.0B | $10.0B | $0 | $17.7B |
| Cash & ST Investments | $22.2B | $18.7B | $11.8B | $3.7B | $40.1B |
| Net Receivables | $8.9B | $1.7B | $446M | $714M | $2.7B |
| Inventory | $3.3B | $2.9B | $2.6B | $1.1B | $1.1B |
| Other Current Assets | $0 | -$1K | $112M | $1.3B | $40M |
| Total Current Assets | $34.9B | $24.0B | $15.2B | $6.8B | $44.0B |
| Property, Plant & Equip. | $6.1B | $6.4B | $2.9B | $3.6B | $3.7B |
| Goodwill & Intangibles | $33.7B | $33.2B | $31.2B | $33.2B | $52.2B |
| Long-Term Investments | $5.0B | $2.5B | $2.6B | $22.7B | $30.4B |
| Other Non-Current Assets | $929M | $1.3B | $914M | $1.4B | $507M |
| Total Non-Current Assets | $45.7B | $43.3B | $37.6B | $60.9B | $86.7B |
| Total Assets | $80.5B | $67.3B | $52.8B | $67.7B | $130.7B |
| — Liabilities — | |||||
| Accounts Payable | $192M | $687M | $431M | $555M | $499M |
| Short-Term Debt | $14.8B | $6.0B | $5.4B | $25.8B | $17.7B |
| Deferred Revenue | $0 | $0 | $0 | $0 | $0 |
| Other Current Liabilities | $1.7B | $2.0B | $860M | $212M | $1.3B |
| Total Current Liabilities | $17.3B | $9.0B | $6.9B | $27.5B | $19.5B |
| Long-Term Debt | $111M | $0 | $0 | $0 | $33M |
| Other Non-Current Liab. | $114M | $57M | $542M | $459M | $421M |
| Total Non-Current Liabilities | $1.7B | $99M | $574M | $780M | $525M |
| Total Liabilities | $19.0B | $9.1B | $7.5B | $28.3B | $20.0B |
| — Equity — | |||||
| Common Stock | $19.3B | $19.8B | $19.9B | $19.9B | $48.0B |
| Retained Earnings | -$90.5B | -$106.3B | -$12.8B | -$19.8B | -$33.7B |
| Accumulated OCI | $45.6B | $44.4B | -$646M | $45.5B | $46.4B |
| Total Stockholders Equity | $61.6B | $58.2B | $45.3B | $39.4B | $110.7B |
| Total Liabilities & Equity | $80.5B | $67.3B | $52.8B | $67.7B | $130.7B |
| — Key Metrics — | |||||
| Total Debt | $15.5B | $6.2B | $5.5B | $26.6B | $17.8B |
| Net Debt | $6.3B | $3.5B | $3.7B | $22.9B | -$4.5B |
| Total Investments | $18.0B | $18.5B | $12.6B | $22.7B | $48.2B |